Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Hach Launches Hach BioTector B3500c TOC Analyzer for Condensate Applications

Published: Monday, March 04, 2013
Last Updated: Monday, March 04, 2013
Bookmark and Share
New analyzer provides maximum reliability and uptime available.

Hach Company has launched a reliable safeguard to sensitive processes in clean water applications, the Hach BioTector B3500c TOC Analyzer.

This analyzer was specifically designed and engineered to meet the requirements of clean water applications including Condensate Return, Cooling Water, Potable Water, Pharmaceutical Water (WFI) and Demineralized Water.

It offers process insights, process incident alerts, environmental monitoring, energy optimization, product and water loss prevention, and boiler and plant protection.

With patented Two Stage Advanced Oxidation Technology, the Hach BioTector B3500c provides the maximum reliability and uptime available, without sacrificing accuracy.

“The Hach BioTector B3500c analyzer uses the same award-winning, patented technology that has given BioTector an international reputation for unparalleled reliability and accuracy,” David Horan, CEO of BioTector said. “Hach’s BioTector B3500c is one example of how customer feedback has helped us develop a new product to service a particular customer segment.”

This analyzer has one of the lowest costs of ownership available, due to many cost saving features.

Unlike other systems that require reagent replacement bi-weekly or monthly, this analyzer only requires replacement every 6 months.

With available wall space being a critical issue for most plants, the Hach BioTector B3500c helps free up space for other needed instruments by having one of the most compact analyzer footprints available.

The analyzer also has the unique ability to monitor two streams at the same time, eliminating the potential double-cost of needing two separate analyzers.

As the most reliable and affordable option available, and with the highest uptime, the Hach BioTector B3500c TOC Analyzer provides immediate direct savings and is the industry’s choice when it comes to TOC analysis for condensate applications.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Hach Company Responds to Storm Sandy
A dedicated support hotline has been established to help customers.
Monday, November 05, 2012
Hach Announces 2011 BIG Picture Contest Grand Prize Winners
Eight other plants expects to receive the Fan Favorite prize of $40,000 in Hach equipment.
Friday, November 11, 2011
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!